122 related articles for article (PubMed ID: 26616862)
1. Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.
Chu PC; Yang MC; Kulp SK; Salunke SB; Himmel LE; Fang CS; Jadhav AM; Shan YS; Lee CT; Lai MD; Shirley LA; Bekaii-Saab T; Chen CS
Oncogene; 2016 Jul; 35(30):3897-908. PubMed ID: 26616862
[TBL] [Abstract][Full Text] [Related]
2. STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
Elife; 2024 Apr; 13():. PubMed ID: 38573819
[TBL] [Abstract][Full Text] [Related]
3. Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.
Donahue TR; Dawson DW
Trends Endocrinol Metab; 2016 Nov; 27(11):770-781. PubMed ID: 27461042
[TBL] [Abstract][Full Text] [Related]
4. STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer.
D'Amico S; Kirillov V; Petrenko O; Reich NC
bioRxiv; 2023 Sep; ():. PubMed ID: 37732258
[TBL] [Abstract][Full Text] [Related]
5. KRAS silencing alters chromatin physical organization and transcriptional activity in colorectal cancer cells.
Martins F; Machado AL; Ribeiro A; Oliveira SM; Carvalho J; Matthiesen R; Backman V; Velho S
Res Sq; 2024 Apr; ():. PubMed ID: 38410476
[TBL] [Abstract][Full Text] [Related]
6. Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.
Chu PC; Kulp SK; Bekaii-Saab T; Chen CS
Small GTPases; 2018 Nov; 9(6):452-456. PubMed ID: 27936345
[TBL] [Abstract][Full Text] [Related]
7. Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.
Chao MW; Chu PC; Chuang HC; Shen FH; Chou CC; Hsu EC; Himmel LE; Huang HL; Tu HJ; Kulp SK; Teng CM; Chen CS
Oncotarget; 2016 Jan; 7(2):1796-807. PubMed ID: 26625202
[TBL] [Abstract][Full Text] [Related]
8. Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells.
Huang HL; Wu HY; Chu PC; Lai IL; Huang PH; Kulp SK; Pan SL; Teng CM; Chen CS
Oncogenesis; 2017 Jul; 6(7):e359. PubMed ID: 28692035
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer.
Chuang HC; Huang PH; Kulp SK; Chen CS
Pharmacol Res; 2017 Mar; 117():370-376. PubMed ID: 28077300
[TBL] [Abstract][Full Text] [Related]
10. Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Chao MW; Tseng YC; Yang MC; Salunke SB; Sullivan NJ; Chen WC; Zhang J; Teng CM; Fu WM; Sun D; Wicha MS; Shapiro CL; Chen CS
Carcinogenesis; 2016 Apr; 37(4):430-442. PubMed ID: 26905583
[TBL] [Abstract][Full Text] [Related]
11. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Kamerkar S; LeBleu VS; Sugimoto H; Yang S; Ruivo CF; Melo SA; Lee JJ; Kalluri R
Nature; 2017 Jun; 546(7659):498-503. PubMed ID: 28607485
[TBL] [Abstract][Full Text] [Related]
12. KIT Exon 11 Codons 557-558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.
Wang HC; Li TY; Chao YJ; Hou YC; Hsueh YS; Hsu KH; Shan YS
Clin Cancer Res; 2016 Jul; 22(14):3477-87. PubMed ID: 26936919
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
Osumi H; Shinozaki E; Osako M; Kawazoe Y; Oba M; Misaka T; Goto T; Kamo H; Suenaga M; Kumekawa Y; Ogura M; Ozaka M; Matsusaka S; Chin K; Hatake K; Mizunuma N
Mol Clin Oncol; 2015 Sep; 3(5):1053-1057. PubMed ID: 26623049
[TBL] [Abstract][Full Text] [Related]
14. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA.
Cogoi S; Rapozzi V; Cauci S; Xodo LE
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1389-1398. PubMed ID: 27888145
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo.
Komar HM; Serpa G; Kerscher C; Schwoegl E; Mace TA; Jin M; Yang MC; Chen CS; Bloomston M; Ostrowski MC; Hart PA; Conwell DL; Lesinski GB
Sci Rep; 2017 May; 7(1):1787. PubMed ID: 28496202
[TBL] [Abstract][Full Text] [Related]
16. Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer.
Zhu Y; Li X; Zhang Q; Yang X; Sun X; Pan Y; Yuan X; Ma Y; Xu B; Yang Z
RSC Med Chem; 2024 May; 15(5):1515-1526. PubMed ID: 38784467
[TBL] [Abstract][Full Text] [Related]
17. Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects.
Han ZQ; Wen LN
World J Gastrointest Oncol; 2023 Jul; 15(7):1149-1173. PubMed ID: 37546556
[TBL] [Abstract][Full Text] [Related]
18. How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors.
Wojtyś W; Oroń M
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296881
[TBL] [Abstract][Full Text] [Related]
19. The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer.
Gu W; Shen H; Xie L; Zhang X; Yang J
Front Oncol; 2022; 12():800140. PubMed ID: 35651786
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches.
Ravinder D; Rampogu S; Dharmapuri G; Pasha A; Lee KW; Pawar SC
Med Oncol; 2022 Apr; 39(5):61. PubMed ID: 35478276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
